DERMATOLOGY

Dermatology trials carry some very unique challenges. From retention difficulties to compliance issues in a patient population that is on average much younger than the norm. Biorasi knows how to make your dermatology trial a success.

Overcoming Complex Dermatology Trial Challenges

Dermatology continues to be on the target list for innovation and product development. Although many consider dermatology to be a simple therapeutic area to tackle, Biorasi understands the unique challenges that still exist. Attracting and enrolling patients can be straightforward, but retaining them throughout a study can be especially difficult. Particularly when working with the skin, the body’s largest organ, environmental and seasonal factors can easily disrupt a patient’s treatment. Acknowledging these and other similar challenges up front and properly factoring them in to trial design is key for trial success.

Dermatology Experience for Dermatology Trial Success

Biorasi’s most recent dermatology experience includes acne, rosacea and psoriasis and many others. Our strategy for success involves leveraging our proprietary site database to select high-performing sites whose primary investigators are up to date on the latest treatments, assessments and clinical scales. We focus on proper patient screening and education, especially when dealing with a younger demographic, to promote compliance and retention. This experience, along with our exceptional clinical team, gives Biorasi the tools to effectively deliver concise solutions for Dermatology trials across the globe.

"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."

VP of Global Clinical Development, Top Specialty Pharma

Latest News and Blogs

Not Enrolling Enough? How to Rescue Your Recruitment Strategy

A common issue regarding “faltering” studies – studies that are not satisfying their time, cost, and quality parameters – is poor recruitment. Recruitment issues can delay deadlines and jeopardize the drug’s ultimate approval, if left unresolved. These delays are a...

Avoiding the Blame-Game in Rescue: Don’t Ask Who, Ask Why

Introduction Clinical trial rescues can often be a delicate topic for both sponsor and contract research organization. When a study goes off track, it’s natural to want to point fingers and look for who is to blame. However, performing a comprehensive root cause...

Contact Biorasi

7 + 12 =